These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2179501)

  • 1. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.
    Whiteside TL; Bryant J; Day R; Herberman RB
    J Clin Lab Anal; 1990; 4(2):102-14. PubMed ID: 2179501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell deficiency.
    Orange JS
    J Allergy Clin Immunol; 2013 Sep; 132(3):515-525. PubMed ID: 23993353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving methods of assessing natural killer cell cytotoxicity.
    Sephton SE; Kraemer HC; Neri E; Stites DP; Weissbecker I; Spiegel D
    Int J Methods Psychiatr Res; 2006; 15(1):12-21. PubMed ID: 16676682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of T, NK and K lymphocytes in two immunodeficiency syndromes].
    Olìnescu A; Hristescu S; Poliopol M; Agachi F
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(2):185-92. PubMed ID: 2888179
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural killer cell biology illuminated by primary immunodeficiency syndromes in humans.
    Voss M; Bryceson YT
    Clin Immunol; 2017 Apr; 177():29-42. PubMed ID: 26592356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-induced natural killer cell loss as a measure of NK cell responses.
    Warren HS
    J Immunol Methods; 2011 Jul; 370(1-2):86-92. PubMed ID: 21689658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood natural killer (NK) cell function in healthy adults assessed using the target-induced NK loss (TINKL) assay.
    Warren HS; Wu F; Horn PL; Pyne DB; West NP; Cripps AW
    J Immunol Methods; 2013 Jun; 392(1-2):68-70. PubMed ID: 23567516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the functional activity of lymphokine-activated killer cells in healthy donors and in patients with interleukin-2-dependent immunodeficiency].
    Petrov RV; Koval'chuk LV; Kalinina AR; Pavliuk AS; Ul'ianova TIu
    Biull Eksp Biol Med; 1989 Jun; 107(6):713-5. PubMed ID: 2790170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of natural killer (NK) cells].
    Abo T
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():189-92. PubMed ID: 9097586
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.
    Villanueva J; Lee S; Giannini EH; Graham TB; Passo MH; Filipovich A; Grom AA
    Arthritis Res Ther; 2005; 7(1):R30-7. PubMed ID: 15642140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculation of lytic units for the expression of cell-mediated cytotoxicity.
    Bryant J; Day R; Whiteside TL; Herberman RB
    J Immunol Methods; 1992 Jan; 146(1):91-103. PubMed ID: 1735786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
    Caligiuri M; Murray C; Buchwald D; Levine H; Cheney P; Peterson D; Komaroff AL; Ritz J
    J Immunol; 1987 Nov; 139(10):3306-13. PubMed ID: 2824604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-induced natural killer cell loss as a measure of NK cell responses.
    Warren H
    Curr Protoc Immunol; 2012 Apr; Chapter 14():Unit 14.29.1-15. PubMed ID: 22470134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
    Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
    J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biology of human natural killer cells.
    Whiteside TL; Herberman RB
    Ann Ist Super Sanita; 1990; 26(3-4):335-48. PubMed ID: 2091502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes.
    Schwarz RE; Hiserodt JC
    J Immunol; 1988 Nov; 141(10):3318-23. PubMed ID: 3263421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assays of natural killer (NK) cell ligation to target cells.
    Renò F; Papa S; Vitale M; Zamai L
    Curr Protoc Cytom; 2001 May; Chapter 9():Unit 9.10. PubMed ID: 18770748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.
    Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S;
    Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.